Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating

  • Delivery technology with application to all non-psychoactive cannabinoids
  • Company is an enabler rather than competitor to hemp oil producers
  • Revenue from licensing DehydraTECH oral digestion technology

Thanks to Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), there’s no need for a spoonful of sugar to help the medicine go down. This innovative biotech has developed technology that masks the strong taste and odor of hemp oil products, eschewing the need for artificial sweeteners, which tend to come with their own fallout to heart and health. Lexaria’s DehydraTECH oral digestion technology is a ‘back office’ process that solves the taste and odor issues that confront all hemp oil producers. With the hemp oil market set to grow 38 percent annually for the near future, Lexaria is well positioned to benefit from the expansion as an enabler rather than competitor. The company intends to license its technology to hemp oil producers, whose numbers continue to rise, and has already tightened its grip on the market with a number of patent filings and registrations.

Hemp might be palatable to a troglodyte, but since it ‘tastes like a handful of grass and dirt’, according to the ‘Made by Hemp’ blog (http://cnw.fm/494Yg), a modern homo sapien, accustomed to his burger and fries, is unlikely to find it palatable. The obvious solution is to complement the intake of hemp with sugars or sweeteners. However, while sugars occurring naturally in fruits and other foods will usually pose no health problem, processed sugar and artificial sweeteners are quite the opposite. “Refined, concentrated sugar consumed in large amounts rapidly increases blood glucose and insulin levels, increases triglycerides, inflammatory mediators and oxygen radicals, and with them, the risk for diabetes, cardiovascular disease and other chronic illnesses,” according to Harvard Health (http://cnw.fm/7gOVL). Moreover, artificial sweeteners can be addictive. One pre-clinical study worryingly demonstrated that rodents, when given a choice between intravenous cocaine and oral saccharine, mostly chose the saccharine.

Read the full article

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer